---
layout: archive
title: "CV"
permalink: /cv/
author_profile: true
redirect_from:
  - /resume
---

{% include base_path %}

Education
======
* M.S. in Genomics and Bioinformatics The Chinese University of Hong Kong, Aug 2020 – Aug 2021
* B.S. in Bioinformatics Harbin Medical University, Sep 2015 – Jun 2020

Work experience
======
* July 2024 - : Laboratory Technician
  * Peking University International Cancer Insititute
  * Supervisor: ZHAN Qimin
    
* Aug 2021 – Sep 2023 : Product Bioinformatics Engineer
    * Geneplus-Beijing Institute, Beijing, China
      * Identification and analysis of Circulating tumor DNA using liquid biopsy technology
      * Pan-organ damage early detection product development
* Jul 2019 – Aug 2019 : Data Analysis of Genome (Intern)
  * Chinese Academy of Sciences 
  * Supervisor: HU Songnian
  
Skills
======
* Computer programming: Linux operating system, statistical analytical and conducting data visualization by using SAS & R, data processing and algorithm 
  development by Python, SQL, Shell, MATLAB, WDL
* Expertise: High-throughput sequencing data analysis, multi-omics data analysis, bioinformatics analysis process construction, data visualization, Statistical analysis and machine learning model development,understand the PyTorch framework
* Professional Certificate
  * Chinese Academy of Sciences Bioinformatics Engineer Qualification Certificate
  * Clinical Genetic Hybridization Testing Laboratory Technician Certificate

Publications
======
1. Yi Pan; Jia-Tao Zhang; Xuan Gao; Zhi-Yong Chen; Bingfa Yan; Pei-Xin Tan; Xiao-Rong Yang; Wei Gao; Yuhua Gong;Zihan Tian; Si-Yang Maggie Liu; Hui Lin; Hao Sun; Jie Huang; Si-Yang Liu; Hong-Hong Yan; Song Dong; Chong-Rui Xu;Hua-Jun Chen; Zhen Wang; Pansong Li; Yanfang Guan; Bin-Chao Wang; Jin-Ji Yang; Hai-Yan Tu; Xue-Ning Yang;Wen-Zhao Zhong; Xuefeng Xia; Xin Yi; Qing Zhou; Yi-Long Wu. **Dynamic Circulating Tumor DNA duringchemoradiotherapy Predicts Clinical Outcomes for Locally Advanced Non-Small Cell Lung CancerPatients.** Cancer Cell 2023 Oct 9;41(10):1763-1773.e4. (IF: 50.3)
2. Wei Gao, Wuqiang Cao, Xiaoling Zeng, Zihan Tian, Xue Zhang, Ning Fu, Pansong Li. **Analytical validation of an NGS-based, personalized and tumor-informed liquid biopsy assay for detecting minimal residual disease (MRD) with high sensitivity and specificity.** [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 5578. (IF: 11.2)
3. Gong Chen, Yongming Zeng, Chunzai Feng, Jingge Yang, Longqing Cheng, Hui Wang, Ligang Xia, Mei Jiang, Xiaozhong Wang, Xiaoling Zeng, Zihan Tian, Ning Fu, Xue Zhang, Wuqiang Cao, Pansong Li, and Wei Gao. **Tumor-informed patient-specific MRD monitoring analysis in colorectal cancer.** Journal of Clinical Oncology 2023 41: 4_suppl, 48-48. (IF: 45.3)
4. Qun Dong, Feng Li, Yanjun Xu, Jing Xiao, Yingqi Xu, Desi Shang, Chunlong Zhang, Haixiu Yang, Zihan Tian, Kai Mi, Xia Li, Yunpeng Zhang, **RNAactDrug: a comprehensive database of RNAs associated with drug sensitivity from multi-omics data.** Briefings in Bioinformatics,bbz142,2019. (IF: 13.9)

  <ul>{% for post in site.publications reversed %}
    {% include archive-single-cv.html %}
  {% endfor %}</ul>
  
## PATENTS
1. Detection methods and applications of tumor-specific mutation status.                                    2023.08 CN patent no. CN116631508A
2. Design methods and applications of cancer species-specific core probe sets for MRD detection.            2023.12 CN patent no. CN117144003A
3. Design method and application of personalized probe set for MRD detection.                               2023.12 CN patent no. CN117144002A
  
